{"&cites=12223866794635153495&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Health policy responses to the financial crisis in Europe edited by Philipa Mladovsky et al.","url":"https://apps.who.int/iris/bitstream/handle/10665/108608/e96643.pdf","authors":["P Mladovsky","P Mladovsky D Srivastava","P Mladovsky D Srivastava J Cylus","P Mladovsky D Srivastava J Cylus M Karanikolos…"],"year":2012,"numCitations":247,"pdf":"https://apps.who.int/iris/bitstream/handle/10665/108608/e96643.pdf","citationUrl":"http://scholar.google.com/scholar?cites=661365681579494414&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:DgwuVZWkLQkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=661365681579494414&hl=en&as_sdt=2005&sciodt=0,5","publication":"apps.who.int","p":1,"exp":1596890268060},{"title":"Encouraging the use of generic medicines: implications for transition economies","url":"https://www.researchgate.net/profile/Panos_Kanavos/publication/11199141_Encouraging_the_use_of_generic_medicines_Implications_for_transition_economies/links/02bfe51076f937cb44000000.pdf","authors":["DR King","DR King P Kanavos"],"year":2002,"numCitations":241,"pdf":"https://www.researchgate.net/profile/Panos_Kanavos/publication/11199141_Encouraging_the_use_of_generic_medicines_Implications_for_transition_economies/links/02bfe51076f937cb44000000.pdf","citationUrl":"http://scholar.google.com/scholar?cites=5837337509666889126&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ph3CmYljAlEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5837337509666889126&hl=en&as_sdt=2005&sciodt=0,5","publication":"researchgate.net"},{"title":"Sustaining generic medicines markets in Europe","url":"https://journals.sagepub.com/doi/abs/10.1057/palgrave.jgm.4940128","authors":["S Simoens","S Simoens S De Coster"],"year":2006,"numCitations":213,"pdf":"https://lirias.kuleuven.be/retrieve/981","citationUrl":"http://scholar.google.com/scholar?cites=6491893617687250022&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ZsTfidnWF1oJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6491893617687250022&hl=en&as_sdt=2005&sciodt=0,5","publication":"journals.sagepub.com"},{"title":"Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand","url":"https://www.degruyter.com/view/journals/fhep/7/1/article-fhep.2004.7.1.1050.xml.xml","authors":["PM Danzon","PM Danzon JD Ketcham"],"year":2004,"numCitations":195,"pdf":"https://www.nber.org/chapters/c9868.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15364481058066387482&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:GtJDKB6aOdUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15364481058066387482&hl=en&as_sdt=2005&sciodt=0,5","publication":"degruyter.com"},{"title":"Marketing of the life sciences: A new framework and research agenda for a nascent field","url":"https://journals.sagepub.com/doi/abs/10.1509/jmkg.73.4.004","authors":["S Stremersch","S Stremersch W Van Dyck"],"year":2009,"numCitations":190,"pdf":"https://personal.eur.nl/stremersch/artikels/Marketing%20of%20the%20Life%20Sciences%20A%20New%20Framework%20and%20Research%20Agenda%20for%20a%20Nascent%20Field.pdf","citationUrl":"http://scholar.google.com/scholar?cites=12198434596334805254&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BiFfoqKLSakJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12198434596334805254&hl=en&as_sdt=2005&sciodt=0,5","publication":"journals.sagepub.com"},{"title":"Competition in off-patent drug markets: Issues, regulation and evidence","url":"https://academic.oup.com/economicpolicy/article-abstract/23/55/500/2918768","authors":["P Kanavos","P Kanavos J Costa"],"year":2008,"numCitations":162,"pdf":"http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/Genericmedicines/CompetitioninOff-PatentDrugMarkets.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11548713844369472125&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fTpHwg1GRaAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11548713844369472125&hl=en&as_sdt=2005&sciodt=0,5","publication":"academic.oup.com"},{"title":"Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?","url":"https://www.sciencedirect.com/science/article/pii/S001429210800024X","authors":["KR Brekke","KR Brekke AL Grasdal","KR Brekke AL Grasdal TH Holmås"],"year":2009,"numCitations":152,"pdf":"https://www.econstor.eu/bitstream/10419/26104/1/538348208.PDF","citationUrl":"http://scholar.google.com/scholar?cites=3215514009468935717&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:JR6wgPTMnywJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3215514009468935717&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Reference pricing of pharmaceuticals","url":"https://www.sciencedirect.com/science/article/pii/S0167629606001275","authors":["KR Brekke","KR Brekke I Königbauer","KR Brekke I Königbauer OR Straume"],"year":2007,"numCitations":149,"pdf":"https://www.econstor.eu/bitstream/10419/25870/1/518892867.PDF","citationUrl":"http://scholar.google.com/scholar?cites=15570379673340373678&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:rmpqR9EZFdgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15570379673340373678&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing","url":"https://www.sciencedirect.com/science/article/pii/S0277953602003787","authors":["S Kwon"],"year":2003,"numCitations":139,"citationUrl":"http://scholar.google.com/scholar?cites=4266525796831663522&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ohUxcZu-NTsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4266525796831663522&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries","url":"https://link.springer.com/article/10.1186/1475-9276-7-12","authors":["MC Gemmill","MC Gemmill S Thomson","MC Gemmill S Thomson E Mossialos"],"year":2008,"numCitations":136,"pdf":"https://link.springer.com/article/10.1186/1475-9276-7-12","citationUrl":"http://scholar.google.com/scholar?cites=6485970869826430493&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:HSaJVyTMAloJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6485970869826430493&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"}]}